BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27623067)

  • 21. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
    Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.
    di Clemente N; Jamin SP; Lugovskoy A; Carmillo P; Ehrenfels C; Picard JY; Whitty A; Josso N; Pepinsky RB; Cate RL
    Mol Endocrinol; 2010 Nov; 24(11):2193-206. PubMed ID: 20861221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients.
    Pabuccu R; Kaya C; Cağlar GS; Oztas E; Satiroglu H
    Reprod Biomed Online; 2009 Nov; 19(5):631-7. PubMed ID: 20021712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
    Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
    Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.
    Baarends WM; Uilenbroek JT; Kramer P; Hoogerbrugge JW; van Leeuwen EC; Themmen AP; Grootegoed JA
    Endocrinology; 1995 Nov; 136(11):4951-62. PubMed ID: 7588229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF.
    Merhi Z; Buyuk E; Berger DS; Zapantis A; Israel DD; Chua S; Jindal S
    Hum Reprod; 2013 Jun; 28(6):1661-9. PubMed ID: 23503941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
    Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
    Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Mullerian hormone (AMH) concentration in follicular fluid and mRNA expression of AMH receptor type II and LH receptor in granulosa cells as predictive markers of good buffalo (Bubalus bubalis) donors.
    Liang A; Salzano A; D'Esposito M; Comin A; Montillo M; Yang L; Campanile G; Gasparrini B
    Theriogenology; 2016 Sep; 86(4):963-970. PubMed ID: 27087535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS).
    Zhong X; Jin F; Huang C; Du M; Gao M; Wei X
    Technol Health Care; 2021; 29(S1):11-25. PubMed ID: 33682741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
    Georgopoulos NA; Karagiannidou E; Koika V; Roupas ND; Armeni A; Marioli D; Papadakis E; Welt CK; Panidis D
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1866-70. PubMed ID: 23969185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Anti-Müllerian Hormone and Its Receptor Expression around Follicle Deviation in Cattle.
    Ilha GF; Rovani MT; Gasperin BG; Ferreira R; de Macedo MP; Neto OA; Duggavathi R; Bordignon V; Gonçalves PB
    Reprod Domest Anim; 2016 Apr; 51(2):188-94. PubMed ID: 26815645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures.
    Fu YX; Yang HM; OuYang XE; Hu R; Hu T; Wang FM
    Reprod Sci; 2021 Feb; 28(2):406-415. PubMed ID: 32845508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.
    Cimino I; Casoni F; Liu X; Messina A; Parkash J; Jamin SP; Catteau-Jonard S; Collier F; Baroncini M; Dewailly D; Pigny P; Prescott M; Campbell R; Herbison AE; Prevot V; Giacobini P
    Nat Commun; 2016 Jan; 7():10055. PubMed ID: 26753790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicle-stimulating hormone suppressed excessive production of antimullerian hormone caused by abnormally enhanced promoter activity in polycystic ovary syndrome granulosa cells.
    Li Y; Wei LN; Liang XY
    Fertil Steril; 2011 Jun; 95(7):2354-8, 2358.e1. PubMed ID: 21514585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Müllerian Hormone (AMH) May Stall Ovarian Cortex Function Through Modulation of Hormone Receptors Other Than the AMH Receptor.
    Detti L; Fletcher NM; Saed GM; Peregrin-Alvarez I; Uhlmann RA
    Reprod Sci; 2018 Aug; 25(8):1218-1223. PubMed ID: 29141508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.